Monitoring human cytomegalovirus infections ganciclovir treatment heart transplant recipients determination viremia antigenemia DNAemia Fourteen heart transplant recipients human cytomegalovirus HCMV infection determination antigenemia viremia DNAemia polymerase chain reaction PCR peripheral blood polymorphonuclear PMNL patients symptomatic primary recurrent asymptomatic seronegative HCMV infection Severe clinical symptoms levels viremia/antigenemia infected cells blood samples positive viremia/antigenemia DNAemia positive DNAemia negative assays HCMV infections heart transplant recipients PCR viral appearance blood days assays antigenemia/viremia hand viral disappearance blood PCR weeks months assays Detection virus PCR overt HCMV-related clinical symptoms symptomatic patients ganiclovir PCR-negative end treatment virus blood following weeks whereas persistent recurrent infection 